ロード中...
Oxiperomide in tardive dyskinesia.
Tardive dyskinesia can be suppressed by dopaminergic receptor blockers, but often at the cost of a reciprocal increase in Parkinsonism. Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evalua...
保存先:
| 出版年: | J Neurol Neurosurg Psychiatry |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1980
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490519/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7373324/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.43.3.264 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|